Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBPET.L Regulatory News (BPET)

  • There is currently no data for BPET

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

1st Quarter Results

26 May 2009 11:08

RNS Number : 7993S
F&C Private Equity Trust PLC
26 May 2009
 



To: Stock Exchange

For immediate release:

26 May 2009

F&C Private Equity Trust plc

Quarterly results for the three months to 31 March 2009 

NAV decrease for the ordinary shares of 6.7%* over quarter to 31st March

NAV increase for the restricted voting shares of 2.5% over the quarter to 31st March

Net out-flow of £1.1m 

* Based on fully diluted NAV

Manager's Review

Introduction

The valuation of the ordinary share pool of the Company at 31st March was £149m, giving a fully diluted NAV per share of 204.15p, a decrease over the quarter of 6.7%. The restricted voting pool was valued at £5.9m, giving an NAV per share of 8.74p, an increase of 2.5%. Foreign exchange movements over the quarter reduced the valuation of the ordinary share pool by 1.7% although there was a minimal effect on the restricted voting pool. 

The ordinary share pool of the Company had net debt of £30.4m at 31st March giving gearing of 16.6%.

The main portfolio events are discussed below, the striking feature being that the net outflow of funds at £1.1m over the quarter was much lower than usual. This attests to the difficulty of effecting private equity deals against the background of recession and the ongoing lack of availability of credit.

New Investments

No new commitments were made during the quarter. The outstanding undrawn commitments of the Company stood at £150.9m at 31st March, a slight decrease over the quarter. Given the current lack of investment activity it is probable that a substantial proportion of these commitments will not be drawn before the relevant fund investment periods expire. It is also expected that the level of commitments will reduce with the sale of non-core positions.

There were a small number of drawdowns over the quarter. In the UK, which accounts for 39% of the ordinary share pool portfolio by value at 31st March, it was especially quiet with new investments of only £0.65m. These drawdowns were for modest follow on investments and fees. In the US, which accounts for only 6.6% of the ordinary share pool portfolio, drawdowns were £0.75m. Most of this was for four investments in the Warburg Pincus funds. In the European focused funds there was more activity with drawdowns totalling £2.9m including four new investments: AIG New Europe Fund drew £0.5m for Sowiniec, a provider of roll-out services to the Polish retail sector; Mezzanine Management IV drew £0.4m for investment in the UK based healthcare company, Vanguard Healthcare, which operates a fleet of 36 mobile operating theatres and diagnostic (e.g. endoscopy) vehicles; Gilde Buy-Out Fund III called £0.4m for investment in electricity infrastructure company Powerlines; and lastly, Ibersuizas Fund II called £0.3m for investment in Hofmann, a company that has been a pioneer in the sale of digital albums.

Realisations

Whilst activity levels in the quarter were low there were some small realisations. Notably Dunedin Capital Partners achieved an excellent sale of aviation navigation company Fernau. This achieved an IRR of 92% and 3x money multiple over its short hold period of just over a year. The inflow for the Company was £0.4m. The other main realisation was the sale of the UK division of healthcare information company, HKI, which was sold by Inflexion 2003 achieving 1.5x cost and returning £0.2m. In the US, Camden Strategic III realised more of its holding in American Public Education, which is now listed, yielding £0.2m. Additional significant inflows came from Stirling Square, returning £1.1m in equalisation payments and Capvis III, returning £0.2m from syndicating Bartec and KVT.

Valuation Changes

The largest individual change during the quarter was a reduction of £2.4m (32%) in the valuation of the European Fund Argan Capital. This is a consequence of the manager factoring lower trading into its valuations. Within our co-investment portfolio we have recognised the difficulties associated with the recession and we have taken full provisions against the value of Equidebt and Eurotel, resulting in downgrades of £1.2m and £0.9m respectively. In both cases, the management teams and the lead private equity managers are working hard to restore equity value. Another significant downgrade of £1.0m is a result of the decline of Candover Investments PLC, which at the end of March was at the low price of 82.5p. It has since recovered to 289p. Other downgrades reflect pressure on profits and ratings of companies which are affected to varying degrees by the recession. In Germany DBAG V has been reduced by £0.5m and, in Spain, Nmas1 by £0.7m.

The portfolio is broad and well diversified and, despite the challenges of the recession, there have been some uplifts. Dunedin Buy-out Fund II and Equity Harvest Fund are up by £0.2m and £0.1m respectively as a result of the Fernau realisation. The mezzanine component of the portfolio is also performing well with most of these funds showing an increase in value over the quarter.

Financing 

The rate of drawdown is, as expected, very slow. This is a reflection of the deteriorating economic situation internationally and the difficulty of raising debt for MBO vehicles. However, there are some sectors where there is significant ongoing activity, notably healthcare. Private equity activity influences the Company through both sales and new investments. This was borne out during the quarter. The drawdowns totalled £4.3m and these were financed by some 75% through realisations (£2.7m) and income (£0.5m) from the portfolio. The result is that whilst we are now using more of our borrowing facility, it is being used slowly. 

As described in the annual report, secondary sales are being undertaken to increase the headroom on our existing facility while we explore several options for larger scale financing, intended to allow the Company to invest through the downturn by meeting all its outstanding commitments. This could include borrowing arrangements to allow the Company, if necessary, to gear up to 30% of total assets, in line with our investment guidelines.

As previously disclosed, our largest holding, the Inflexion led co-investment in Viking Moorings, continues to make good fundamental progress and remains in a live sale process. This gives a prospect of cash inflow and a reduction in the Company's debt.

Outlook

The recovery in the Company's share price from its low in March reflects investment by new shareholders, the wider stock market rally and a realisation that prices in the listed private equity sector were factoring in an unrealistically poor outcome. There remain substantial challenges for our investee funds and companies and for the Company itself. The interests of our investment partners are closely aligned with ours and all of them are very clear in their objective which is to build equity value through the recession. Their considerable skill and experience is being deployed on our behalf to meet the challenges of the recession. 

For more information, please contact:

Hamish Mair

0131 718 1184

Martin Cassels

0131 718 1095

hamish.mair@fandc.commartin.cassels@fandc.com 

  F&C PRIVATE EQUITY TRUST plc

Income Statement for the 

three months ended 31 March 2009

Unaudited

Revenue

£'000

Capital

£'000

Total

£'000

Losses on investments

-

(12,041)

(12,041)

Currency gains

-

1,635

1,635

Income

523

-

523

Investment management fee

(87)

(259)

(346)

Other expenses

(153)

-

(153)

_______

_______

_______

Net return before finance costs and taxation

283

(10,665)

(10,382)

Interest payable and similar charges

(76)

(229)

(305)

_______

_______

_______

Return on ordinary activities before taxation

207

(10,894)

(10,687)

Taxation on ordinary activities

(60)

60

-

_______

_______

_______

Return on ordinary activities after taxation 

147

(10,834)

(10,687)

_______

_______

_______

Returns per Ordinary share - Basic

0.20p

(15.19)p

(14.99)p

_______

_______

_______

Returns per Ordinary share - Fully diluted

0.20p

(14.79)p

(14.59)p

_______

_______

_______

Returns per Restricted Voting share - Basic

0.00p

0.21p

0.21p

_______

_______

_______

  F&C PRIVATE EQUITY TRUST plc

Income Statement for 

three months ended 31 March 2008

Unaudited

Revenue

£'000

Capital

£'000

Total

£'000

Gains on investments

-

6,412

6,412

Currency losses

-

(21)

(21)

Income

355

-

355

Investment management fee

(101)

(1,104)

(1,205)

Other expenses

(129)

-

(129)

_______

_______

_______

Net return before finance costs and taxation

125

5,287

5,412

Interest payable and similar charges

(8)

(22)

(30)

_______

_______

_______

Return on ordinary activities before taxation

117

5,265

5,382

Taxation on ordinary activities

(36)

36

-

_______

_______

_______

Return on ordinary activities after taxation 

81

5,301

5,382

_______

_______

_______

Returns per Ordinary share - Basic

0.03p

6.91p

6.94p

_______

_______

_______

Returns per Ordinary share - Fully diluted

0.03p

6.73p

6.76p

_______

_______

_______

Returns per Restricted Voting share - Basic

0.09p

0.46p

0.55p

_______

_______

_______

  

F&C PRIVATE EQUITY TRUST plc

Income Statement for 

year ended 31 December 2008

Audited

Revenue

£'000

Capital

£'000

Total

£'000

Losses on investments

-

(2,825)

(2,825)

Currency losses

-

(4,903)

(4,903)

Income

2,043

-

2,043

Investment management fee

(202)

216

14

Other expenses

(669)

-

(669)

_______

_______

_______

Net return before finance costs and taxation

1,172

(7,512)

(6,340)

Interest payable and similar charges

(159)

(477)

(636)

_______

_______

_______

Return on ordinary activities before taxation

1,013

(7,989)

(6,976)

Taxation on ordinary activities

(265)

74

(191)

_______

_______

_______

Return on ordinary activities after taxation 

748

(7,915)

(7,167)

_______

_______

_______

Returns per Ordinary share - Basic

0.66p

(11.98)p

(11.32)p

_______

_______

_______

Returns per Ordinary share - Fully diluted

0.64p

(11.66)p

(11.02)p

_______

_______

_______

Returns per Restricted Voting share - Basic

0.41p

1.11p

1.52p

_______

_______

_______

  F&C PRIVATE EQUITY TRUST plc

BALANCE SHEET

As at 31 March 2009

(unaudited)

As at 31 March 2008

(unaudited)

As at 31 December 2008

 (audited)

£000

£000

£000

£000

£000

£000

Investments at market value

Listed on recognised exchanges

1,328

9,340

1,329

Unlisted at directors' valuation

183,791

165,976

194,009

_______

_______

_______

185,119

175,316

195,338

Current assets

Debtors

649

292

740

Cash at bank

3,061

7,041

4,436

_______

_______

_______

3,710

7,333

5,176

Creditors

Amounts falling due within one year

(33,945)

(1,054)

(34,943)

_______

_______

_______

Net current (liabilities)/assets 

(30,235)

6,279

(29,767)

_______

_______

_______

Total assets less current liabilities

154,884

181,595

165,571

_______

_______

_______

Creditors

Amounts falling due after more than one year

-

(1,626)

-

_______

_______

_______

Net assets

154,884

179,969

165,571

_______

_______

_______

  F&C PRIVATE EQUITY TRUST plc

BALANCE SHEET (CTD)

As at 31 March 2009

(unaudited)

As at 31 March 2008

(unaudited)

As at 31 December 2008

(audited)

£000

£000

£000

Capital and reserves

Called up ordinary capital

1,394

1,394

1,394

Special distributable capital reserve

15,679

15,679

15,679

Special distributable revenue reserve

37,692

38,363

37,692

Capital redemption reserve

664

664

664

Capital reserve

98,721

122,771

109,555

Revenue reserve

734

1,098

587

_______

_______

_______

Total shareholders' funds

154,884

179,969

165,571

_______

_______

_______

Net asset value per Ordinary share - Basic

206.17p

240.77p

221.15p

Net asset value per Ordinary share - Fully diluted

204.15p

237.84p

218.74p

Net asset value per Restricted Voting share - Basic

8.74p

8.85p

8.53p

  F&C PRIVATE EQUITY TRUST plc

RECONCILIATION OF MOVEMENTS IN SHAREHOLDERS' FUNDS

Three months ended

31 March 2009

(unaudited)

Three months ended

31 March 2008

(unaudited)

Year ended 

31 December 2008

(audited) 

Opening equity shareholders' funds

165,571

198,908

198,908

Return on ordinary activities after taxation

(10,687)

5,382

(7,167)

Dividends paid

-

-

(1,178)

Special dividends paid

-

-

(671)

Return of capital paid

-

(24,321)

(24,321)

_______

_______

_______

Closing equity shareholders' funds

154,884

179,969

165,571

_______

_______

_______

  

Notes

 

 

1. The unaudited quarterly results have been prepared on the basis of the accounting policies set out in the statutory accounts of the Company for the year ended 31 December 2008.

2. These are not full statutory accounts in terms of Section 240 of the Companies Act 1985. The full audited accounts for the year to 31 December 2008, which were unqualified, have been lodged with the Registrar of Companies. The quarterly report will be available on the Company's website.

 

3. Returns per Restricted Voting share are based on the average number of shares in issue during the period of 67,084,807.

Returns per Ordinary share are based on the following average number of shares in issue during the period:-

Basic 72,282,273

Fully diluted 74,241,429

Basic net asset value per Restricted Voting share is based on 67,084,807 shares in issue at the end of the period.

Basic net asset value per Ordinary share is based on 72,282,273 shares in issue at the end of the period.

Fully diluted net asset value per Ordinary share is based on 74,241,429 shares in issue at the end of the period.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
QRFEAESKAESNEFE
Date   Source Headline
30th Jun 20223:22 pmRNSChange of Name
17th Jun 20224:07 pmRNSTransaction in Own Shares
15th Jun 20225:01 pmRNSTransaction in Own Shares
27th May 20229:08 amRNSResult of Annual Gen Meeting & Directorate Change
26th May 202212:02 pmRNS1st Quarter Results
27th Apr 202210:07 amRNSDirector/PDMR Shareholding
27th Apr 202210:06 amRNSDirector/PDMR Shareholding
27th Apr 202210:04 amRNSDirector/PDMR Shareholding
26th Apr 20223:24 pmRNSDirector/PDMR Shareholding
26th Apr 20223:23 pmRNSDirector/PDMR Shareholding
25th Apr 20229:24 amRNSDirector/PDMR Shareholding
8th Apr 20227:00 amRNSAnnual Financial Report
1st Apr 202210:17 amRNSHolding(s) in Company
1st Apr 202210:09 amRNSHolding(s) in Company
30th Mar 20222:56 pmRNSDirector/PDMR Shareholding
30th Mar 20222:54 pmRNSDirector/PDMR Shareholding
25th Mar 20227:00 amRNSAnnual Financial Report
17th Feb 20227:00 amRNSDirectorate Change
14th Jan 20227:00 amRNSUpdate on Secondary Placing
13th Jan 20227:00 amRNSProposed Secondary Placing
4th Jan 20227:00 amRNSInvestor Presentation
26th Nov 20217:00 amRNS3rd Quarter Results
22nd Nov 202110:47 amRNSHolding(s) in Company
15th Oct 20219:55 amRNSHolding(s) in Company
15th Oct 20217:00 amRNSKepler Trust Intelligence: New Research
27th Aug 20217:00 amRNSInterim results and Quarterly Dividend
25th Jun 20213:14 pmRNSHolding(s) in Company
27th May 20212:15 pmRNSAGM Statement
27th May 202111:51 amRNSQuarterly NAV and Dividend Announcement
29th Apr 20211:01 pmRNSHolding(s) in Company
19th Apr 20217:00 amRNSAnnual Financial Report
26th Mar 20217:00 amRNSFinal Results
24th Mar 20217:00 amRNSInvestment Update
8th Feb 20213:00 pmRNSHolding(s) in Company
9th Dec 20209:22 amRNSHolding(s) in Company
27th Nov 202010:52 amRNSHolding(s) in Company
25th Nov 20209:18 amRNSKepler Trust Intelligence: New Research
20th Nov 20207:00 amRNSQuarterly results and dividend announcement
15th Oct 20204:09 pmRNSNon-Executive Director Declaration
18th Sep 20202:09 pmRNSDirector/PDMR Shareholding
16th Sep 20202:24 pmRNSDirector/PDMR Shareholding
15th Sep 20203:42 pmRNSHolding(s) in Company
1st Sep 202012:24 pmRNSDirector/PDMR Shareholding
21st Aug 20207:00 amRNSInterim Results
20th Jul 20207:00 amRNSNon-Executive Director Declaration
17th Jul 20207:00 amRNSAppointment of Corporate Broker
9th Jun 20209:57 amRNSHolding(s) in Company
4th Jun 20207:00 amRNSDirectorate Change
22nd May 20204:11 pmRNSHolding(s) in Company
21st May 20207:00 amRNSFirst Quarter Results and Dividend Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.